A prospective randomized controlled trial of subcutaneous passive drainage for the prevention of superficial surgical site infections in open and laparoscopic colorectal surgery

2014 ◽  
Vol 29 (3) ◽  
pp. 353-358 ◽  
Author(s):  
Masakatsu Numata ◽  
Teni Godai ◽  
Junya Shirai ◽  
Kazuteru Watanabe ◽  
Daisuke Inagaki ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Colorectal Surgery ◽  
Laparoscopic Colorectal Surgery ◽  
Controlled Trial ◽  
Surgical Site Infections ◽  
Randomized Controlled ◽  
Prospective Randomized Controlled Trial

scholarly journals Liposomal bupivacaine addition versus standard bupivacaine alone for colorectal surgery: a randomized controlled trial

2021 ◽  
Author(s):  
Yar L Yeap ◽  
John Wolfe ◽  
Jennifer Stewart ◽  
Amy McCutchan ◽  
Gulraj Chawla ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Colorectal Surgery ◽  
Laparoscopic Colorectal Surgery ◽  
Controlled Trial ◽  
Liposomal Bupivacaine ◽  
Randomized Controlled ◽  
Pain Scores ◽  
Quadratus Lumborum ◽  
Prospective Randomized Controlled Trial ◽  
Registration Number

Aim: This study evaluated use of liposomal bupivacaine (LB) versus standard bupivacaine (SB) alone in quadratus lumborum (QL) blocks for laparoscopic colorectal surgery. Materials & methods: In this prospective, randomized controlled trial, patients received QL1 blocks with either LB (40 ml 0.125% SB plus 20 ml of LB) or SB (60 ml of 0.25% SB) with 30 ml per side. Opioid usage, pain scores, side effects and other medications were recorded. Results: For 78 patients (38 LB; 40 SB), all parameters were similar between groups, except that the LB group had a higher 48 h need for metoclopramide. Conclusion: LB provided no analgesic benefit over SB alone for QL blocks. Clinical Trials registration number: NCT03702621

Sign in / Sign up

Export Citation Format

Share Document